The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126628611 12662861 1 I 20160719 20160818 20160818 EXP US-STRIDES ARCOLAB LIMITED-2016SP010467 STRIDES HAN Z, KANE BM, PETTY LA, JOSEPHSON MA, SUTOR J, PURSELL KJ. COBICISTAT SIGNIFICANTLY INCREASES TACROLIMUS SERUM CONCENTRATIONS IN A RENAL TRANSPLANT RECIPIENT WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION. PHARMACOTHERAPY. 2016;36(6):50-53 0.00 Y 0.00000 20160818 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126628611 12662861 1 PS TACROLIMUS. TACROLIMUS 1 2 MG, EVERY 12 HRS U 90687 2 MG
126628611 12662861 2 I STRIBILD COBICISTATELVITEGRAVIREMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 ONE PILL, QD 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126628611 12662861 1 Immunosuppression
126628611 12662861 2 HIV infection

Outcome of event

Event ID CASEID OUTC COD
126628611 12662861 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126628611 12662861 Abdominal pain upper
126628611 12662861 Acute kidney injury
126628611 12662861 Blood creatinine increased
126628611 12662861 Drug interaction
126628611 12662861 Drug level above therapeutic
126628611 12662861 Headache
126628611 12662861 Hyperkalaemia
126628611 12662861 Insomnia
126628611 12662861 Toxicity to various agents
126628611 12662861 Urine output decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found